Report overview
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Drugs. This report contains market size and forecasts of Gastrointestinal Drugs in global, including the following market information:
Global Gastrointestinal Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gastrointestinal Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Gastrointestinal Drugs companies in 2022 (%)
The global Gastrointestinal Drugs market was valued at US$ 35710 million in 2022 and is projected to reach US$ 44110 million by 2029, at a CAGR of 3.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.
We surveyed the Gastrointestinal Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastrointestinal Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastrointestinal Drugs Market Segment Percentages, by Type, 2022 (%)
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Global Gastrointestinal Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastrointestinal Drugs Market Segment Percentages, by Application, 2022 (%)
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
Global Gastrointestinal Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastrointestinal Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastrointestinal Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastrointestinal Drugs revenues share in global market, 2022 (%)
Key companies Gastrointestinal Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gastrointestinal Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastrointestinal Drugs, market overview.
Chapter 2: Global Gastrointestinal Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastrointestinal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastrointestinal Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
